Skip to main content

Advertisement

Open Peer Review Reports for: Effect of KRAS codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study group

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
18 Sep 2011 Submitted Original manuscript
16 Oct 2011 Reviewed Reviewer Report - Susan Richman
2 Nov 2011 Reviewed Reviewer Report - Frederic Bibeau
4 Nov 2011 Reviewed Reviewer Report - katia bencardino
25 Feb 2012 Author responded Author comments - Anke Reinacher-Schick
Resubmission - Version 2
25 Feb 2012 Submitted Manuscript version 2
6 Mar 2012 Reviewed Reviewer Report - Susan Richman
13 Mar 2012 Reviewed Reviewer Report - katia bencardino
11 Apr 2012 Reviewed Reviewer Report - Frederic Bibeau
23 Apr 2012 Author responded Author comments - Anke Reinacher-Schick
Resubmission - Version 3
23 Apr 2012 Submitted Manuscript version 3
8 May 2012 Reviewed Reviewer Report - Susan Richman
15 Jun 2012 Author responded Author comments - Anke Reinacher-Schick
Resubmission - Version 4
15 Jun 2012 Submitted Manuscript version 4
Publishing
26 Jun 2012 Editorially accepted
9 Aug 2012 Article published 10.1186/1471-2407-12-349

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement